During the recent session, Colgate-Palmolive Company (NYSE:CL)’s traded shares were 1.3 million, with the beta value of the company hitting 0.55. At the last check today, the stock’s price was $78.12, reflecting an intraday gain of 0.74% or $0.57. The 52-week high for the CL share is $85.61, that puts it down -9.59 from that peak though still a striking 7.58% gain since the share price plummeted to a 52-week low of $72.20. The company’s market capitalization is $64.35B, and the average intraday trading volume over the past 10 days was 6.99 million shares, and the average trade volume was 5.77 million shares over the past three months.
Colgate-Palmolive Company (CL) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.80. CL has a Sell rating from 1 analyst(s) out of 24 analysts who have looked at this stock. 15 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 1 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.79.
Colgate-Palmolive Company (NYSE:CL) trade information
Colgate-Palmolive Company (CL) registered a 0.74% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 0.74% in intraday trading to $78.12 this Thursday, 05/12/22, hitting a weekly high. The stock’s 5-day price performance is 1.92%, and it has moved by -4.26% in 30 days. Based on these gigs, the overall price performance for the year is -6.86%. The short interest in Colgate-Palmolive Company (NYSE:CL) is 9.34 million shares and it means that shorts have 1.67 day(s) to cover.
The consensus price target of analysts on Wall Street is $82.80, which implies an increase of 5.65% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $71.00 and $91.00 respectively. As a result, CL is trading at a discount of -16.49% off the target high and 9.11% off the low.
Colgate-Palmolive Company (CL) estimates and forecasts
Statistics show that Colgate-Palmolive Company has outperformed its competitors in share price, compared to the industry in which it operates. Colgate-Palmolive Company (CL) shares have gone down -1.19% during the last six months, with a year-to-date growth rate more than the industry average at -4.05% against -11.10. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 2.60% this quarter and then jump 2.50% in the quarter after that. In the rating firms’ projections, revenue will increase 6.10% compared to the previous financial year.
Revenue for the current quarter is expected to be $4.46 billion as predicted by 11 analyst(s). Meanwhile, a consensus of 8 analyst(s) estimates revenue growth to $4.49 billion by the end of Mar 2022. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $4.32 billion and $4.34 billion respectively. In this case, analysts expect current quarter sales to grow by 3.30% and then jump by 3.40% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -1.20%. While earnings are projected to return -18.60% in 2022, the next five years will return 4.11% per annum.
Colgate-Palmolive Company is due to release its next quarterly earnings between April 28 and May 02. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Colgate-Palmolive Company is 1.88, with the dividend yield indicating at 2.42 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 2.33%.
Colgate-Palmolive Company (NYSE:CL)’s Major holders
Colgate-Palmolive Company insiders own 0.09% of total outstanding shares while institutional holders control 81.13%, with the float percentage being 81.20%. Vanguard Group, Inc. (The) is the largest shareholder of the company, while 2,229 institutions own stock in it. As of Dec 30, 2021, the company held over 76.75 million shares (or 9.13% of all shares), a total value of $6.55 billion in shares.
The next largest institutional holding, with 65.22 million shares, is of Blackrock Inc.’s that is approximately 7.76% of outstanding shares. At the market price on Dec 30, 2021, these shares were valued at $5.57 billion.
Also, the Mutual Funds coming in first place with the largest holdings of Colgate-Palmolive Company (CL) shares are Vanguard Total Stock Market Index Fund and Vanguard Specialized-Dividend Growth Fund. Data provided on Dec 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 23.95 million shares. This amounts to just over 2.85 percent of the company’s overall shares, with a $2.04 billion market value. The same data shows that the other fund manager holds slightly less at 20.83 million, or about 2.48% of the stock, which is worth about $1.59 billion.